title: Molecular modeling and pharmacological analysis of species-related histamine H(3) receptor heterogeneity.
abstract: Presynaptic histamine H(3) receptors (H(3)R) regulate neurotransmitter release in the central nervous system, suggesting an important role for H(3) ligands in human diseases such as cognitive disorders, sleep disturbances, epilepsy, or obesity. Drug development for many of these human diseases relies upon rodent-based models. Although there is significant sequence homology between the human and rat H(3)Rs, some compounds show distinct affinity profiles. To identify the amino acids responsible for these species disparities, various mutant receptors were generated and their pharmacology studied. The N-terminal portion was shown to determine the species differences in ligand binding since a chimeric H(3)R containing N-terminal human and C-terminal rat receptor sequences exhibited similar pharmacology to the human receptor. Sequence analysis and molecular modeling studies suggested key amino acids at positions 119 and 122 in transmembrane region 3 play important roles in ligand recognition. Mutant receptors changing amino acids 119 or 122 of the human receptor to those in the rat improved ligand binding affinities and functional potencies of antagonist ligands, confirming the significant role that these amino acids play in species-related pharmacological differences. A model has been developed to elucidate the ligand receptor interactions for H(3)Rs, and pharmacological aspects of this model are described.
authors.affiliation: Neuroscience Research, Abbott Laboratories, R4MN, AP9A, 100 Abbott Park Road, Abbott Park, IL 60064, USA. betty.yao@abbott.com
authors.forename: B B
authors.initials: BB
authors.lastname: Yao
authors.forename: C W
authors.initials: CW
authors.lastname: Hutchins
authors.forename: T L
authors.initials: TL
authors.lastname: Carr
authors.forename: S
authors.initials: S
authors.lastname: Cassar
authors.forename: J N
authors.initials: JN
authors.lastname: Masters
authors.forename: Y L
authors.initials: YL
authors.lastname: Bennani
authors.forename: T A
authors.initials: TA
authors.lastname: Esbenshade
authors.forename: A A
authors.initials: AA
authors.lastname: Hancock
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D001667:Binding, Competitive; D002460:Cell Line; D002540:Cerebral Cortex / Q000378:metabolism; D003001:Cloning, Molecular; D006633:Histamine Antagonists / Q000494:pharmacology*; D006801:Humans; D008958:Models, Molecular; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D011869:Radioligand Assay; D051381:Rats; D018100:Receptors, Histamine H3 / Q000187:drug effects* / Q000235:genetics* / Q000502:physiology; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D016415:Sequence Alignment; D013045:Species Specificity
chemical_list: D006633:Histamine Antagonists; D018100:Receptors, Histamine H3; D011993:Recombinant Fusion Proteins